Consensus Elanco Animal Health Incorporated Deutsche Boerse AG

Equities

5EA

US28414H1032

Market Closed - Deutsche Boerse AG 02:05:10 2024-05-28 am EDT 5-day change 1st Jan Change
15.34 EUR -0.13% Intraday chart for Elanco Animal Health Incorporated -1.29% +16.02%

Evolution of the average Target Price on Elanco Animal Health Incorporated

Price target over the last 5 years

History of analyst recommendation changes

0869ffe32.6O49UcX2ikNKDp3B2l6f4YSU8QUuIZunFfcUOLvB89M.nYRuOIqB4jYuZvqpoz_2kerjwmNAEs_wU7ksbuqMrIyQvUUz9cTANyhgxA~4c3b6fa4bee89ba2b12b19e3dc6b381f
Piper Sandler Adjusts Price Target on Elanco Animal Health to $19 From $18, Maintains Neutral Rating MT
Barclays Raises Elanco Animal Health Price Target to $23 From $19, Maintains Overweight Rating MT
BofA Securities Adjusts Price Target on Elanco Animal Health to $20 From $18, Maintains Buy Rating MT
Morgan Stanley Adjusts Elanco Animal Health's Price Target to $17 From $16, Keeps Overweight Rating MT
Goldman Sachs Raises Price Target on Elanco Animal Health to $14 From $12.50, Maintains Sell Rating MT
Barclays Adjusts Price Target on Elanco Animal Health to $19 From $18, Maintains Overweight Rating MT
Goldman Sachs Adjusts Elanco Animal Health's Price Target to $12.50 From $10, Keeps Sell Rating MT
Stifel Upgrades Elanco Animal Health to Buy From Hold, Raises Price Target Price Target to $20 From $13 MT
Jefferies Initiates Elanco Animal Health at Buy Rating With $17 Price Target MT
Morgan Stanley Upgrades Elanco Animal Health to Overweight From Equalweight, Price Target is $16 MT
Stifel Trims Price Target on Elanco Animal Health to $12 From $13, Maintains Hold Rating MT
Piper Sandler Adjusts Price Target on Elanco Animal Health to $13 From $9, Maintains Neutral Rating MT
Goldman Sachs Adjusts Price Target on Elanco Animal Health to $9.50 From $8.50, Maintains Sell Rating MT
Piper Sandler Adjusts Elanco Animal Health Price Target to $9 From $12, Maintains Neutral Rating MT
Goldman Sachs Adjusts Price Target on Elanco Animal Health to $9 From $10.50, Maintains Sell Rating MT
Barclays Upgrades Elanco Animal Health to Overweight From Equalweight, Price Target is $14 MT
Goldman Sachs Cuts Elanco Animal Health's Price Target to $10.50 From $12, Maintains Sell Rating MT
Barclays Trims Price Target on Elanco Animal Health to $14 From $18, Keeps Equalweight Rating MT
Morgan Stanley Adjusts Price Target on Elanco Animal Health to $19 From $20, Maintains Equalweight Rating MT
Morgan Stanley Adjusts Price Target on Elanco Animal Health to $20 From $21, Maintains Equalweight Rating MT
Piper Sandler Slashes Price Target on Elanco Animal Health to $15 From $21, Affirms Neutral Rating MT
JPMorgan Lowers Elanco Animal Health's Price Target to $17 From $20, Maintains Neutral Rating MT
Goldman Sachs Adjusts Elanco Animal Health Price Target to $12 From $19, Maintains Sell Rating MT
JPMorgan Chase Lowers Elanco Animal Health's Price Target to $20 From $24, Maintains Neutral Rating MT
Morgan Stanley Adjusts Elanco Animal Health Price Target to $21 From $22, Maintains Equal Weight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
17.14 USD
Average target price
19.11 USD
Spread / Average Target
+11.52%
High Price Target
23 USD
Spread / Highest target
+34.19%
Low Price Target
16 USD
Spread / Lowest Target
-6.65%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Elanco Animal Health Incorporated

Piper Sandler
Barclays
BofA Securities
Goldman Sachs
Morgan Stanley
Stifel Nicolaus
Jefferies & Co.
JPMorgan Chase
Cleveland Research
Gabelli
Credit Suisse
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
  1. Stock Market
  2. Equities
  3. ELAN Stock
  4. 5EA Stock
  5. Consensus Elanco Animal Health Incorporated